Immunovant, Inc. (NASDAQ:IMVT) is held by 193 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 319,980 | 5.58% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | 2,261,199 | 15.35% | $0.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 0 | 1,798,126 | 18.48% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -211,843 | -47.69% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 952,504 | 13.95% | $0.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 0 | 469,164 | 9.08% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 1,338 | 0.00% | $0.00 |
| ARMISTICE CAPITAL, LLC | 31 Dec, 2025 | 0 | -88,845 | -1.52% | $0.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 0 | 2,720,183 | 121.34% | $0.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Two Seas Capital LP | 31 Dec, 2025 | 0 | 104,922 | 3.80% | $0.00 |
| Alpine Global Management, LLC | 31 Dec, 2025 | 0 | -255,078 | -4.63% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | -1,442,078 | -41.90% | $0.00 |
| Morgan Stanley | 31 Dec, 2025 | 0 | 2,887,359 | 147.39% | $0.00 |
| Woodline Partners LP | 31 Dec, 2025 | 0 | 477,144 | 31.84% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 894,308 | 30.92% | $0.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 0 | 1,660,933 | 0.00% | $0.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 0 | 3,177,850 | 0.00% | $0.00 |
| Logos Global Management LP | 31 Dec, 2025 | 0 | 1,100,000 | 400.00% | $0.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 0 | 407,000 | 25.63% | $0.00 |